~~<i id='6D5D354FD8'><strike id='6D5D354FD8'><tt id='6D5D354FD8'><pre id='6D5D354FD8'></pre></tt></strike></i>~~

Home» leisure time» focus

focus

author：Wikipedia 2025-10-06 13:02:27 Page View：49981

Hiram Secrist (left), who has Duchenne muscular dystrophy, with his mother, Kristen Secrist (center), and his grandmother, Terrie Jordan. Courtesy Secrist family

In mid-July, Kristen Secrist hopped on a call with her 5-year-old son’s doctor, who had urgent news: The first gene therapy had been approved for Duchenne muscular dystrophy. Her son, Hiram, would be a perfect candidate — if, she added, they could get him dosed in time.

The treatment was approved only for 4- and 5-year-olds. Hiram turned 6 in three weeks.

“Oh, crap,” Secrist said to herself.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： GOP inquiry over gain
Next article： What does generative AI mean for health care? We asked experts

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Supreme Court rules employers must be more accommodating of religious observance

3:53TheU.S.SupremeCourtisseenonJune23,2023inWashington,D.C.KevinDietsch/GettyImagesAunanimousSupreme

The high cost of giving birth even with insurance

AdobeTheburdenofhighhealthcarecostsandmedicaldebtintheU.S.isnosecret.Medicaldebtaffectsoneinfiveadul

Belarusian journalist sentenced to 4 years in prison as crackdown continues

TALLINN,Estonia--ABelarusianjournalistwassentencedFridaytofouryearsinprisonafterbeingconvictedofaidi